Other studies have demonstrated that circHIF1A contributes to the metastasis of BC to lymph nodes by binding to miR-149-5p and inhibiting cyclin-dependent kinase inhibitor 1 (P21), the main target of P53. Here, CDKN1A is linked to breast cancer.